Medical News: FDA Approves REMS for Drugs That Combat Anemia - in Product Alert, Prescriptions from MedPage Today

Links shared publicly online about this topic.

  • 1,377
    total visits

Medical News: FDA Approves REMS for Drugs That Combat Anemia - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com —

WASHINGTON -- The FDA has announced a formal strategy to reduce the risks of erythropoiesis-stimulating agents (ESAs) for cancer patients who take the drugs to treat anemia caused by chemotherapy.

View full resource at medpagetoday.com

Tags: Anemia, Anemia Medication, Cancer, Chemotherapy, Drug, FDA, Aranesp, Procrit

  • Share

Most Recently Shared on February 17, 2010 at 2:49 am By:

Lymphomation Lymphomation.org

FDA approves REMS to reduce risks of Procrit, Aranesp, other ESAs. http://bit.ly/aGkjV0

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

FightCancer FightCancer

medical_tweets medical_tweets

Advertisement